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• Lysosomes are the final repository of degradation 
products from the extracellular and intracellular spaces. The 
lysosomal membrane forms a unique vacuole participating in 
both endocytosis and autophagocytosis (1). It is extremely 
resistant to degradation by lysosomal hydrolases, maintains 
an acidic intralysosomal environment, transports amino acids 
and oligosaccharides produced by lysosomal hydrolases, in 
teracts and fuses with other membrane organelles, such as 
endosomes and phagosomes, and with the plasma membrane: 
(2,3). 
STRUCTURE, BIOGENESIS, AND INTRACELLULAR 
TRAFFICKING  OF  LYSOSOMAL  MEMBRANE-
ASSOCIATED   GLYCOPROTEINS 
• The knowledge on the structure of lysosomal mem 
branes was enriched by identifying lysosomal membrane 
proteins unique to lysosomes. The lysosomal membrane- 
associated glycoproteins (Lamp-1 and Lamp-2) were ob 
tained from various species. The human cDNA encoding their 
polypeptide chains has also been isolated (4-6). Interspecies 
homology within each type of Lamps is high, e.g. human and 
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mouse Lamp-1 share about 66% homology. Sequence ho-
mologies between the two groups, however, are less, human 
Lamp-1 being approximately 35% homologous to Lamp-2 
(7). Lamps are encoded by genes localized to different 
chromosomes, Lamp-1 to 13q34, Lamp-2 to Xq24-25 (8). It 
could be speculated that the two genes were most likely produced 
by a duplication of a primordial gene early in evolution (6). 
Studies on the Lamp-2 protein family revealed that they are 
conserved from birds to mammals, and the diversity is generated 
by alternative splicing of a single Lamp-2 gene (9). Lamps 
contain a polypeptide core of approximately 43 kD. They are 
synthesized as precursor molecules (90 kD) that are processed 
to mature glycoproteins of approximately 110 kD (Lamp-1), 
and 105 kD (Lamp-2) (10, 11). The larger part of the molecule, 
extensively glycosylated (N- and O-glycans), is located at the 
luminal side of the lysosome, and is connected to a 
transmembrane domain extended to a short cytoplasmic tail 
(Fig. 1). The intraluminal domain contains two internally 
homologous domains separated by a region rich in proline 
residues. The homologous domains have eight half-cysteine 
residues connected in disulfide loops much like the immuno-
globulin molecules. The position of the cysteine residues is 
conservedbetween Lamp-1 and Lamp-2 molecules, and among 
different species. 
Several observations prompt that the mechanism of Lamp 
traffic to lysosomes differs from that of lysosomal enzymes 
(Fig. 2). By expressing Lamp-1 cDNA in COS-1 cells it was 
first shown that the tyrosine residue in the cytoplasmic tail is 
essential for the delivery of Lamp molecules to lysosomes 
(12). Two possible routes to reach lysosomes are discussed 
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Figure 1. Structure of Lamp-1. Lamp-2 has an almost identical configuration, (modified after Ref 1) 
  
for Lamps : (i) Lamps are sorted among other proteins at the 
trans-Golgi cisternae, transported to late endosomes and then to 
lysosomes together with newly synthesized lysosomal 
enzymes, and (ii) Lamps are first transported to the cell 
surface along with the secretory protein pathway and then 
sorted from plasma membrane proteins by selective internali-
zation, followed by transport to dense lysosomes (13). 
Recent studies provide evidence that the majority of newly 
synthesized Lamps is directly transported to lysosomes (1), 
while soluble lysosomal enzymes are transported to pre-
lysosomes (endosomes) by binding to the mannose-6-phos-
phate receptors (14). 
LYSOSOMAL MEMBRANE-ASSOCIATED 
GLYCOPROTEINS OH THE CELL SURFACE - 
ADHESION MOLECULES ? 
• . Although the molecular structure of Lamps is well 
determined, their biological role remains unclear. These 
molecules focus the current interest of many scientists 
because of the diverse biological functions suggested as well 
as for their peculiar appearance on the plasma membrane, 
unclarified yet. There has been some controversy whether or 
not Lamps are expressed on the cell surface. Immunoelectron 
microscopy failed to detect any surface Lamps, while by 
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Figure 2. Trafficking of newly synthesized Lamp molecules. Lamps exit from the trans-Golgi and enter the endosome 
compartment. Most Lamps are transported to prelysosomes together with lysosomal enzymes. The majority of them enter 
lysosomes, but some are transported to the plasma membrane and exocytosed. A small part of Lamps are targetted to the 
plasma membrane probably via a default pathway. Then they return to endosomes, and through the endocytic pathway 
finally reach lysosomes. (modified after Ref 1) ________ 
  
face in minor quantities depending on the cell type and 
differentiation stage (15). Only a small amount of the total 
number of Lamps can be detected on the cell surface - only 2% of 
total labelled Lamp-1 was expressed on the HL-60 cell 
surface (14). Considering that Lamps are the major cellular 
sialoglycoproteins, their expression constitues more than 
50000 Lamp molecules on the plasma membrane (3). The 
transport kinetics of Lamp-1 to the surface of pulse-labelled 
biotinylated HL-60 cells showed that its maximal expression 
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amounts decreased, indicating that the molecules were 
internalized. The half-time for internalization was found to be 
13 min (12). These experiments reveal that the exact duration 
of the cell cycle, the stage of differentiation, and the cell viability 
are important parameters to be considered when examining cell 
surface Lamps. 
LYSOSOMAL MEMBRANE-ASSOCIATED 
GLYCOPROTEINS IN CANCER CELLS 
• It was found that highly metastatic tumor cells ex 
press more plasma membrane-bound Lamp molecules than 
poorly metastatic ones (16). There are results strongly sug 
gesting that the high metastatic potential is most likely due to 
the increased amount of poly-N-acetyllactosamines in Lamps 
(16). It is interesting to know how do the sugar residues lead 
to a higher incidence of tumor metastasis. Such unique carbo 
hydrates may protect ly sosomal membranes and provide ligands 
on the cell surface for cell adhesion molecules. Lamp-land 
Lamp-2 are highly sialylated glycoproteins, suggesting that 
one of their functions is to maintain an acidic intralysosomal 




 are ligands for adhesion molecules. It is also 
demonstrated that the extent of adhesion to E-selectin is 
proportional to the amount of cell surface Lamp-1, and to the 
cell surface sialyl-Le
x
 determinants in colonic carcinoma 
cells (16). Most of these results are obtained following 
genetic manipulations, e.g. by overexpression of Lamps or by 
expressing a mutant Lamp molecule preferentially at the 
plasma membrane rather than in lysosomes. The incubation of 
tumor cells having few plasma membrane Lamp molecules 
with sodium butyrate results in a significant increase in the 
amount of Lamps expressed on the cell surface (18, 19). The 
sodium butyrate is known to affect cell growth by arresting the 
cell cycle at the Gl/S phase transition point (20). It also 
causes changes in DNA methylation (21), and in chromatin 
conformation (22, 23). However, the exact mechanism by 
which butyrate augments surface human Lamps is not clear. 
We are currently investigating the mRNA level in butyrate 
treated and untreated cancer cells. 
The augmented expression in malignant cells of some 
endogenous galactoside-binding lectins (galectins), suggests 
that these lectins may play an important role in the 
transformation process and in metastasis (24), e.g. cell surface 
galectin-3 was found to mediate homotypic cell adhesion in 
insect cells (25). Interestingly, the cellular ligands for galectin-
3 are Lamp-1 and Lamp-2 (26). It is possible that, by 
interacting with galectin-3, surface Lamps facilitate both 
the adhesion of tumor cells to extracellular matrix proteins 
and the invasion process itself (18). Being ligands for E-
selectin, Lamps may mediate binding of cancer cells to 
endothelial cells, and thus 
promote metastasis. Therefore, the expression of Lamps in 
malignant cells may depend on their surrounding matrices, 
and may play a role in tumor invasion and metastasis. It is 
interesting to know whether cell surface Lamps detected in 
some tumor cells are normal Lamp molecules transported 
back to the cytoplasm via internalization, or proteins trans 
ported by a default pathway destined to serve as ligands in 
tumor development. This speculation reinforces the impor 
tance of understanding the pattern of Lamps expression in 
malignant cells in cell culture and in vivo. Almost all data 
available are based on the examination of monolayer cell 
cultures. It is therefore reasonable to study biopsy specimens 
in order to determine the level of expression of Lamps, and 
their interactions with adhesion molecules in situ.  
LYSOSOMAL MEMBRANE-ASSOCIATED 
GLYCOPROTEINS IN PLATELETS 
•           Increased amounts of Lamp-1 and Lamp-2 on the cell 
surface are recorded in thrombin-activated platelets (7, 27). 
Platelet Lamp-1 may be of lysosomal origin and becomes 
incorporated into the plasma membrane during secretion (7). 
Secretion in response to a signal from cellular storage pools is 
a general feature of many cells, including platelets. It is 
believed that during exocytosis the granule membrane proteins 
are incorporated in the plasma membrane. Lamp-1, being 
such a protein, could also be translocated to the plasma 
membrane this way. The significant and regulated cell surface 
presence of Lamp-1 on platelets indicates that at least some 
normal adult human cells could express this glycoprotein in 
certain conditions. Activated platelets share some surface 
functional characteristics with malignant cells, such as 
enhanced adhesiveness and protease activity. It is possible that 
the regulated expression of Lamps on activated platelets may 
contribute to these functions. It was shown that a deglyco-
sylated form of Lamp binds collagen and the fibronectin 
adhesion motif ROD (Arg-Gly-Asp), thus suggesting a possible 
role in cell-matrix adhesion (28). Moreover, the amount of cell 
surface Lamp-2 was found to correlate with platelet 
activation in cancer patients with prethrombotic state: platelets, 
from, healthv; individuals, showed low surface levels of Lamp-
2 in contrast to cancer patients having significantly elevated 
expression (29). Therefore, the cell membrane expression of 
Lamps may be an informative indicator of in vivo platelet 
activation, and thus serve as an useful parameter in 
identifying patients with prethrombotic disorders. On the 
other hand, platelets become activated in vitro upon storage 
and this leads to a decrease in the utility of concentrates stored for 
transfusion. Recently, a simple and effective fiowcyto-metric 
test was introduced to evaluate the quality of stored platelet 
concentrates by measuring the level of plasma membrane bound 
Lamp-1 and Lamp-2 (30). 
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LYSOSOMAL MEMBRANE-ASSOCIATED GLYCOPROTEINS IN 
LEUKOCYTES 
• Lamp-1 and Lamp-2 were detected on the surface of 
peripheral blood lymphocytes in patients with scleroderma 
and systemic lupus erythematosus (31). Their expression was 
significantly augmented following phytohemagglutinin stimu 
lation. Lamps likely contribute to the migration of activated 
leukocytes to sites of inflammation. Holcombe et ol (32) 
reported that the surface expression of Lamps on peripheral 
blood mononuclear cells correlated with serum interleukin-8 
and soluble interleukin-2 receptor levels, shorter disease 
duration, and greater functional impairement in patients with 
systemic lupus erythematosus. As Lamps could be shuttled to 
the plasma membrane during cell activation, their elevated 
expression on mononuclear cells may reflect immune system 
activation in scleroderma patients. Moreover, their surface 
expression correlates with clinical and laboratory parameters 
of disease development (33), and thus may be an useful 
indicator of disease activity in patients with autoimmune 
diseases. 
Dahlgren et al (34) showed the presence of Lamps in both 
neutrophil lysosomes and secretory organelles, thus 
speculating that Lamps may play a role in the inflammatory 
response. During phagocytosis, Lamp-1 and Lamp-2 become 
markedly concentrated around the ingested particle, and 
appear on the cell surface when the secretory organelles are 
mobilized (34). Thus, Lamps could be part of a mobilizable 
system designed to recognize and eliminate microbial agents, 
as they carry polylactosaminoglycans containing selectin 
ligands. Since recognition of microorganisms often involves 
microbial lectins (35), surface Lamps may serve as adhesion 
molecules facilitating the binding to bacterial lectins; type-1 
fimbrated Escherichia coli binds to neutrophil Lamp-1 (36). 
These results support the data that Lamps are localized in 
secretory organelles of human neutrophils, suggesting that 
these glycoproteins may play a role on the surface of activated/ 
extravasated neutrophils. 
CONCLUSION 
• Although the molecular structure of Lamps is well 
determined, their biological role is still unclear. Recent 
results suggest that Lamp-1 and Lamp-2 could be regarded as 
a new family of adhesive glycoproteins participating in tumor 
invasion and metastasis, bacterial binding, inflammation, and 
platelet activation as well as in neuronal injury in status 
epilepticus. Future studies may contribute to the application 
of Lamp-1 and Lamp-2 as prognostic parameters in clinical 
oncology and immunology. 
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